Genes Chromosomes and Cancer · 2002 · 152 citations · 22 references
MedicineGeneticsOncologyCancer GeneticsCarcinogenesisMolecular OncologyCancer Cell SignalingCancer ProgressionOncogenic Signaling PathwaysProstate CancerProstate PathologySignal Transduction In CancerApc InactivationBeta-catenin RegulationCancer Signaling PathwaysMolecular Mechanisms Of CarcinogenesisProstate Carcinogenesis
Genetic alterations serve as beacons for the involvement of specific pathways in tumorigenesis. It was previously shown that 5% of prostate tumors harbor CTNNB1 mutations, suggesting that this tumor type may involve a deregulated APC/CTNNB1 pathway. To explore this possibility further, we searched for mutations in genes implicated in this pathway in 22 samples that included cell lines, xenografts, and primary tumors. We identified seven alterations: two in CTNNB1, three in APC, and two in hTRCP1 (also known as BTRC) which controls the degradation of CTNNB1. Alterations in the CTNNB1 regulatory domain, APC, and hTRCP1 were mutually exclusive, consistent with their equivalent effects on CTNNB1 stability. These results suggest that CTNNB1 signaling plays a critical role in the development of a significant fraction of prostate cancers. Moreover, they provide the first evidence that hTRCP1 plays a role in human neoplasia.
22
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Patrice J. Morin, Andrew B. Sparks, Vladimír Kořínek et al. · Science · 1997 · 3.9K citations
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Bonnee Rubinfeld, Iris Albert, Emilio Porfiri et al. · Science · 1996 · 1.4K citations
Stabilization of β-Catenin by Genetic Defects in Melanoma Cell Lines
Bonnee Rubinfeld, Paul F. Robbins, Mona El‐Gamil et al. · Science · 1997 · 1.2K citations